FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.
The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic ...
By leveraging Unfold AI's planning with the Focal One robotic HIFU platform, EDAP and Avenda believe that urologists can ...
The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, aimed at delivering ...
Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market FRUZAQLA Capsules 1mg/5mg (generic name: ...
New legislation in New Jersey would create travel advisories regarding reproductive health access in other states.
Physicians fear use of weight loss drugs in teens will increase or exacerbate eating disorder cases, adding complexity to ...